|
US2007031409A1
|
|
Recombinant DNA-molecule complex for the expression of anti-human-interferon-gamma chimeric antibodies or antibody fragments
|
|
AU7847501A
|
|
Pharmaceutical composition and method for the treatment of retroviral infections
|
|
WO0118003A1
|
|
Carbocyclic nucleosides and process for obtaining such
|
|
WO9730064A1
|
|
Hexitol containing oligonucleotides and their use in antisense strategies
|
|
EP0736302A2
|
|
Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors
|
|
EP0777676A1
|
|
Sequence-specific binding oligomers for nucleic acids and their use in antisense strategies
|
|
EP0733369A1
|
|
Protease inhibitors, a DNA construct for the expression of a protease and a process for measuring proteases and/or protease inhibitors
|
|
AU2063795A
|
|
T-lymphotropic primate virus l (ptlv-l) and its applications
|
|
NL9400932A
|
|
T-Lymphotropic primate virus L (PTLV-L) and uses thereof
|
|
NL9301929A
|
|
Recombinant interleukin-1 Beta
|
|
NL9300058A
|
|
1,5-anhydrohexitol nucleoside analoga and pharmaceutical use thereof.
|
|
EP0530407A1
|
|
Substituted, nucleoside derivatives, methods for their preparation and pharmaceutical compositions containing them
|
|
NL9101290A
|
|
Recombinant dna molecula for the expression of an fv fragment of an antibody.
|
|
US5137724A
|
|
Combinations of TS-inhibitors and viral TK-inhibitors in antiherpetic medicines
|
|
US5116822A
|
|
Therapeutic application of dideoxycytidinene
|
|
WO9003978A1
|
|
5-halogeno-3'-fluoro-2',3'-dideoxyuridine compounds and their therapeutic application
|
|
NL8901258A
|
|
New 5-halo-2'-3'-di:deoxy-cytidine derivs. - useful as anti-retro-viral agents, esp. for treating HIV infections
|
|
NL8900442A
|
|
Sulfated vinyl polymers in medicines for treating retrovirus infections.
|
|
EP0316592A2
|
|
3'-Fluoro-2',3'-dideoxyuridine, and its therapeutic application
|
|
EP0311107A2
|
|
Anti-HIV active 3'-fluoro-purine-2',3'-dideoxyribosides
|
